Biogen Commits $2 Billion to U.S. Expansion Amid Tariff Threats
Biogen will invest an additional $2 billion into its North Carolina manufacturing facilities, joining a growing list of drugmakers ramping up U.S. production as tariff threats loom ...
Read moreDetails
